National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Radiation Countermeasures
 Program
 Research Areas
 Resources
 Funding
 Summaries and Publications
 Congressional Testimonies


 Medical Countermeasures Against Radiological and Nuclear Threats Program

This is a program of the Department of Health and Human Services, Office of Public Health Emergency Medical Countermeasures, and the National Institutes of Health. The program is coordinated by the National Institute of Allergy and Infectious Diseases, with the involvement of the National Cancer Institute.

Program Highlights

  • Introduction
  • Scientific Background
  • Strategic Planning
  • Basic and Translational Goals
  • Focused Research and Product Development Goals
  • Infrastructure Goals
  • Radiation Biodosimetry Goals
  • NIH Strategic Plan
    (PDF, 3.39 MB)
  • Research Areas

  • Radiation Biodosimetry Research and Development
  • Countermeasures Research and Development
  • Resources for Researchers

  • Resources and Links
  • FDA Corner
  • Project Bioshield
  • Funding

  • Awardees—Updated October 7, 2008
  • Centers for Medical Countermeasures Against Radiation (CMCR)
  • Current Opportunities—Updated January 23, 2009
  • Expired Opportunities
  • Summaries, Publications, and Testimony

  • Meeting Summaries and Publications
  • Meeting/Workshop Slides
  • Congressional Testimony
  • News Releases

  • NIAID Announces 25 New Awards to Develop Radiation Countermeasures—October 7, 2008
  • Calendar of Events

  • International Meetings and Training—Updated December 22, 2008
  • back to top

    Highlights

    RFA-DK-08-010: Intestinal Stem Cell Consortium (U01) - Co-Funded by the NIAID Radiation/Nuclear Program.  Receipt date: March 18, 2009.

    Pre-Solicitation Notice issued by BARDA, HHS, January 16, 2009: Advanced Therapeutics for Treating Neutropenia Resulting from Acute Exposure to Ionizing Radiation

    Presolicitation Notice Issued by BARDA, HHS, January 16, 2009: Point of Care of High-Throughput Biological Assays for Determining Absorbed Ionizing Radiation Dose (Biodosimetry) after Radiologic and Nuclear Events.

    See Also

  • Radiological and Nuclear Threats News Releases
  • Division of Allergy, Immunology, and Transplantation (DAIT)
  • Biodefense—The NIAID Biodefense Web site includes biodefense-related information for biomedical researchers, the public, and the media.
  • E-mail Icon E-mail this page
    Print Icon Print this page
    Plug-ins and Viewers
    To open PDFs on this page, download and install the Adobe Acrobat Reader.

    Highlights

    RFA-DK-08-010: Intestinal Stem Cell Consortium (U01) - Co-Funded by the NIAID Radiation/Nuclear Program.  Receipt date: March 18, 2009.

    Pre-Solicitation Notice issued by BARDA, HHS, January 16, 2009: Advanced Therapeutics for Treating Neutropenia Resulting from Acute Exposure to Ionizing Radiation

    Presolicitation Notice Issued by BARDA, HHS, January 16, 2009: Point of Care of High-Throughput Biological Assays for Determining Absorbed Ionizing Radiation Dose (Biodosimetry) after Radiologic and Nuclear Events.

    See Also

  • Radiological and Nuclear Threats News Releases
  • Division of Allergy, Immunology, and Transplantation (DAIT)
  • Biodefense—The NIAID Biodefense Web site includes biodefense-related information for biomedical researchers, the public, and the media.